The abstract is read at the publisher; the summary is JClub's.
ZFP384 drives dysfunctional microglia after stroke by diminishing recovery-phase gene expression, and antisense oligonucleotides targeting Zfp384 sustain reparative function to enhance chronic recovery.
- Why it matters: Spontaneous functional recovery after brain injury fades within months, and the cellular and molecular mechanisms behind the loss of microglia-driven repair remain unclear.
- What they did: Using cellular fate analysis, the study identifies ZFP384 as a transcriptional regulator that reduces YY1-mediated chromatin interactions needed for recovery-phase gene induction in microglia.
- The result: Antisense oligonucleotides targeting Zfp384 sustain microglia’s broad neural repair effects and enhance recovery after stroke, including in the chronic phase of ischaemic stroke.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.